Biospeedia

UNKNOWN, FR · 1 known investors

BioSpeedia develops and produces rapid diagnostic test kits for detecting infectious diseases, including COVID-19, meningitis, and pneumococcal infections, for use by health professionals and patients. The kits use immunochromatographic testing to detect antigens or antibodies and deliver results within minutes.